In 2009, the Centers for Medicare & Medicaid Services publicly reported hospital-level risk-standardized 30-day mortality and readmission rates after acute myocardial infarction (AMI) and heart failure (HF). The authors calculated 30-day mortality and readmission rates for all Medicare...

In 2009, the Centers for Medicare & Medicaid Services publicly reported hospital-level risk-standardized 30-day mortality and readmission rates after acute myocardial infarction (AMI) and heart failure (HF). The authors calculated 30-day mortality and readmission rates for all Medicare...

Telemedicine may hold promise for reducing access barriers for chronically ill Medicare beneficiaries. To evaluate the effectiveness of home telemedicine, Congress mandated a two-phase demonstration to improve primary care for Medicare beneficiaries with diabetes living in medically underserved...

Telemedicine may hold promise for reducing access barriers for chronically ill Medicare beneficiaries. To evaluate the effectiveness of home telemedicine, Congress mandated a two-phase demonstration to improve primary care for Medicare beneficiaries with diabetes living in medically underserved...

In 2007, highly publicized warnings suggested rosiglitazone, a drug used to treat type 2 diabetes, may be associated with an increased risk of heart attack and cardiovascular-related death. This article details the response to these warnings by analyzing anti-diabetes drug use before and after...

This article assesses racial and ethnic differences in asthma prevalence, treatment patterns, and outcomes for children enrolled in the Department of Defense’s health insurance program, TRICARE.